Stage Iiib Breast Cancer
📧 Sign up to get email alerts when something new happens for Stage Iiib Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of cyclophosphamide and veliparib for locally advanced or metastatic breast cancer; the st…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer [NA]
This clinical trial update reports the termination of a study evaluating chemotherapy before surgery and tissue sample collection in patient…
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer [Phase 2]
A Phase 2 trial evaluating fulvestrant with or without bortezomib in patients with operable locally advanced or metastatic estrogen receptor…
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating accelerated radiation therapy after surgery for breast cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer [Phase 2]
Phase 2 trial update evaluating Cu64-DOTA-trastuzumab PET imaging and biomarkers to predict response to neoadjuvant trastuzumab plus pertuzu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Phase II Study of Everolimus Beyond Progression [Phase 2]
Phase II trial evaluating Everolimus beyond progression in breast cancer was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors [Phase 2]
Phase 2 trial evaluating docosahexaenoic acid (DHA) in breast cancer survivors has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus [Phase 2]
Phase 2 clinical trial evaluating a mucoadhesive oral wound rinse to prevent and treat stomatitis in patients with ER- or PR-positive metast…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating vaccine therapy in combination with Rintatolimod and/or Sargramostim for HER2-positive breas…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer [Phase 2]
Phase 2 trial evaluating omega-3 fatty acid in treating various stages of breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update investigating carboplatin and eribulin mesylate in triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer [Phase 2]
Phase 2 trial evaluating trastuzumab and pertuzumab or bevacizumab with combination chemotherapy in stage II–III breast cancer has completed…
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy plus bevacizumab for HER2-negative breast cancer in stage II/III; the study has been terminated with r…
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer [Phase 2]
A phase 2 trial evaluating carboplatin with combination chemotherapy, with or without veliparib, in patients with stage IIB–IIIC breast canc…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy and peripheral blood stem cell transplant followed by Aldesleukin and Sargramostim in inflammatory Sta…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer [Phase 2]
Phase 2 trial evaluating a neoadjuvant regimen of sunitinib, paclitaxel, doxorubicin, and cyclophosphamide in stage IIB-IIIC breast cancer; …
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms [Phase 2]
Phase 2 clinical trial evaluating zoledronic acid for aromatase inhibitor-induced musculoskeletal symptoms in breast cancer patients has com…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer [NA]
This trial evaluated gene-expression-guided selection of neoadjuvant therapy for breast cancer patients before surgery, comparing hormone th…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating Akt inhibitor MK2206 in advanced breast cancer has completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial investigating tipifarnib and fulvestrant in hormone receptor-positive metastatic breast cancer has completed with res…
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer [Phase 1, Phase 2]
Clinical trial update on tipifarnib in combination chemotherapy for stage II/III breast cancer, including Phase 1 and Phase 2 results comple…
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating neoadjuvant tipifarnib with docetaxel and capecitabine in adults with locally advanced or metastatic bre…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study of suramin in combination with paclitaxel for women with stage IIIB t…
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating goserelin with letrozole or anastrozole in premenopausal women with stage II-III estrogen receptor-positive breast …
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen [Phase 2]
A Phase 2 study evaluated the combination of lapatinib and tamoxifen in patients with locally advanced or metastatic breast cancer that prog…